Plus Therapeutics (PSTV) Short Interest Ratio & Short Volume $1.30 +0.01 (+0.78%) (As of 11/13/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Plus Therapeutics Short Interest DataPlus Therapeutics (PSTV) has a short interest of 52,300 shares, representing 0.91% of the float (the number of shares available for trading by the public). This marks a -3.15% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.7, indicating that it would take 0.7 days of the average trading volume of 62,374 shares to cover all short positions.Current Short Interest52,300 sharesPrevious Short Interest54,000 sharesChange Vs. Previous Month-3.15%Dollar Volume Sold Short$68,774.50Short Interest Ratio0.7 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares5,900,000 sharesFloat Size5,750,000 sharesShort Percent of Float0.91%Today's Trading Volume128,145 sharesAverage Trading Volume62,374 sharesToday's Volume Vs. Average205% Short Selling Plus Therapeutics? Sign up to receive the latest short interest report for Plus Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPSTV Short Interest Over TimePSTV Days to Cover Over TimePSTV Percentage of Float Shorted Over Time Ad Crypto 101 MediaThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech giants are quietly integrating it. Venture capitalists are scrambling to invest.Click here to discover our #1 crypto for the market right now – poised for massive growth Plus Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202452,300 shares $68,774.50 -3.2%0.9%0.7 $1.32 10/15/202454,000 shares $76,140.00 -43.4%0.9%0.9 $1.41 9/30/202495,400 shares $139,284.00 +81.0%1.7%1.3 $1.46 9/15/202452,700 shares $77,996.00 +51.0%0.9%1 $1.48 8/31/202434,900 shares $49,907.00 -58.2%0.6%0.6 $1.43 8/15/202483,500 shares $116,900.00 -35.3%1.4%1.4 $1.40 Get the Latest News and Ratings for PSTV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Plus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/31/2024129,000 shares $232,200.00 -39.3%2.3%2.2 $1.80 7/15/2024212,600 shares $389,058.00 -9.2%3.8%2.4 $1.83 6/30/2024234,100 shares $344,127.00 +14.0%4.2%3.1 $1.47 6/15/2024205,300 shares $410,600.00 +19.9%3.7%2.7 $2.00 5/31/2024171,300 shares $378,573.00 +6.5%3.1%2.4 $2.21 5/15/2024160,800 shares $373,056.00 +248.8%2.9%2.2 $2.32 4/30/202446,100 shares $80,237.05 -0.9%1.1%0.7 $1.74 4/15/202446,500 shares $80,910.00 -0.6%1.1%1.5 $1.74 3/31/202446,800 shares $84,474.00 +45.3%1.1%1.5 $1.81 3/15/202432,200 shares $55,706.00 -21.1%0.8%0.9 $1.73 2/29/202440,800 shares $79,152.00 -12.1%1.0%1.1 $1.94 2/15/202446,400 shares $92,336.00 +7.2%1.0%1.2 $1.99 1/31/202443,300 shares $87,033.00 -25.3%1.0%0.6 $2.01 1/15/202458,000 shares $120,060.00 +21.9%1.3%0.2 $2.07 12/31/202347,600 shares $83,304.76 -26.3%1.1%0.2 $1.75 12/15/202364,600 shares $123,386.00 -25.5%1.5%0.2 $1.91 11/30/202386,700 shares $147,390.00 -59.7%2.0%0.1 $1.70 11/15/2023215,000 shares $406,350.00 +441.6%4.9%0.3 $1.89 10/31/202339,700 shares $48,434.00 -43.8%0.9%0.1 $1.22 10/15/202370,600 shares $97,428.00 -27.6%2.5%0.2 $1.38 9/30/202397,500 shares $130,650.00 -30.6%3.4%0.2 $1.34 9/15/2023140,500 shares $195,295.00 +347.5%5.0%0.3 $1.39 8/31/202331,400 shares $87,606.00 -50.4%1.1%0.1 $2.79 8/15/202363,300 shares $153,819.00 +76.8%2.2%1.5 $2.43 7/31/202335,800 shares $88,068.00 +35.6%1.4%1 $2.46 7/15/202326,400 shares $54,648.00 -13.2%1.1%0.8 $2.07 6/30/202330,400 shares $61,408.00 -24.6%1.2%1 $2.02 6/15/202340,300 shares $122,512.00 -3.8%1.6%1.5 $3.04 5/31/202341,900 shares $168,438.00 -14.3%1.7%1.7 $4.02 5/15/202348,900 shares $213,693.00 +154.7%2.0%1.9 $4.37 4/30/202319,200 shares $74,822.40 -66.6%0.8%0.8 $3.90 4/15/202357,500 shares $15,939.00 -76.7%N/A0.2 $0.28 3/31/2023247,100 shares $71,659.00 -13.8%N/A0.9 $0.29 3/15/2023286,600 shares $80,391.30 +4.1%N/A0.9 $0.28I was wrong. Dead wrong. (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. 2/28/2023275,400 shares $93,691.08 -31.4%N/A0.8 $0.34 2/15/2023401,600 shares $156,624.00 -14.9%N/A1.2 $0.39 1/31/2023472,000 shares $204,517.60 +17.2%N/A1.4 $0.43 1/15/2023402,600 shares $192,523.32 +39.7%N/A1.2 $0.48 12/30/2022288,200 shares $91,359.40 -31.9%N/A0.7 $0.32 12/15/2022423,100 shares $132,007.20 -5.0%N/A0.6 $0.31 11/30/2022445,200 shares $179,282.04 -17.8%N/A0.5 $0.40 11/15/2022541,500 shares $234,956.85 -11.4%N/A0.4 $0.43 10/31/2022610,900 shares $287,123.00 -50.3%N/A0.1 $0.47 10/15/20221,230,000 shares $642,060.00 +388.9%N/A0.3 $0.52 9/30/2022251,600 shares $111,962.00 +74.0%N/A0.1 $0.45 9/15/2022144,600 shares $89,565.24 -73.5%N/A0 $0.62 8/31/2022545,600 shares $457,976.64 +865.7%N/A0.1 $0.84 8/15/202256,500 shares $32,041.15 +289.7%N/A0 $0.57 7/31/202214,500 shares $7,176.05 -67.5%N/A0.2 $0.49 7/15/202244,600 shares $22,643.42 +117.6%0.4%0.4 $0.51 6/30/202220,500 shares $11,072.05 +57.7%0.2%0.1 $0.54 6/15/202213,000 shares $7,280.00 +106.4%0.1%0.1 $0.56 5/31/20226,300 shares $3,525.48 -43.2%N/A0 $0.56 5/15/202211,100 shares $5,376.84 -77.3%N/A0.1 $0.48 4/30/202248,900 shares $32,763.00 -49.2%N/A0.2 $0.67 4/15/202296,300 shares $87,536.70 +154.1%N/A0.3 $0.91 3/31/202237,900 shares $37,900.00 -58.3%N/A0 $1.00 3/15/202290,900 shares $87,264.00 -69.7%N/A0 $0.96 2/28/2022300,000 shares $312,000.00 +11.4%N/A0.1 $1.04 2/15/2022269,400 shares $280,176.00 -38.3%1.3%0.1 $1.04 1/31/2022436,400 shares $411,961.60 +70.2%2.9%0.1 $0.94 1/15/2022256,400 shares $264,092.00 +594.9%1.7%0.1 $1.03 12/31/202136,900 shares $38,745.00 -0.3%N/A0 $1.05 12/15/202137,000 shares $44,400.00 -62.7%0.3%0.1 $1.20 11/30/202199,100 shares $148,650.00 -13.1%0.7%0.3 $1.50 11/15/2021114,000 shares $191,520.00 +91.6%0.8%0.1 $1.68 10/29/202159,500 shares $113,050.00 -47.9%0.4%0 $1.90 10/15/2021114,200 shares $199,850.00 -28.5%0.8%0.1 $1.75 9/30/2021159,600 shares $304,836.00 -66.0%1.1%0.1 $1.91 9/15/2021469,400 shares $868,390.00 +121.0%3.1%0.3 $1.85 8/31/2021212,400 shares $414,180.00 +41.7%1.4%0.2 $1.95 8/13/2021149,900 shares $311,792.00 -40.8%1.3%0.3 $2.08 7/30/2021253,400 shares $481,460.00 -14.1%2.1%0.6 $1.90 7/15/2021295,000 shares $660,800.00 -9.7%2.9%0.3 $2.24 6/30/2021326,700 shares $836,352.00 -3.9%3.2%0.3 $2.56 6/15/2021340,100 shares $925,072.00 -65.0%3.7%0.3 $2.72 5/28/2021972,000 shares $2.30 million -28.5%10.7%0.8 $2.37 5/14/20211,360,000 shares $2.77 million +34.7%15.0%1.1 $2.04 4/30/20211,010,000 shares $2.41 million +103.3%11.3%0.6 $2.39 4/15/2021496,700 shares $1.09 million +30.9%5.6%0.5 $2.19 3/31/2021379,600 shares $903,448.00 +125.3%4.2%0.4 $2.38 3/15/2021168,500 shares $500,445.00 +12.4%1.9%0.2 $2.97 2/26/2021149,900 shares $449,700.00 -2.9%1.7%0.2 $3.00 2/12/2021154,300 shares $524,620.00 +2.7%3.4%0.2 $3.40I was wrong. Dead wrong. (Ad)I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. 1/29/2021150,300 shares $371,241.00 +440.7%3.3%0.4 $2.47 1/15/202127,800 shares $65,886.00 -25.1%0.6%0.1 $2.37 12/31/202037,100 shares $77,539.00 -52.8%0.8%0.1 $2.09 12/15/202078,600 shares $158,772.00 +104.7%1.8%0.3 $2.02 11/30/202038,400 shares $82,176.00 -65.5%0.9%0.1 $2.14 11/15/2020111,300 shares $254,877.00 -29.2%2.5%0.1 $2.29 10/30/2020157,300 shares $353,925.00 -28.6%3.5%0.2 $2.25 10/15/2020220,400 shares $579,652.00 -42.1%4.9%0.2 $2.63 9/30/2020380,500 shares $974,080.00 +29.6%9.1%0.4 $2.56 9/15/2020293,500 shares $889,305.00 +6.9%7.3%0.3 $3.03 8/31/2020274,500 shares $672,525.00 -7.6%6.9%0.5 $2.45 8/14/2020297,100 shares $879,416.00 -15.8%7.5%0.7 $2.96 7/31/2020353,000 shares $857,790.00 +34.7%8.8%0.8 $2.43 7/15/2020262,000 shares $581,640.00 +80.0%6.8%0.9 $2.22 6/30/2020145,600 shares $307,216.00 -21.3%3.8%0.5 $2.11 6/15/2020184,900 shares $360,555.00 +246.9%4.8%0.3 $1.95 5/29/202053,300 shares $85,813.00 -5.3%1.4%0.1 $1.61 5/15/202056,300 shares $119,919.00 +305.0%1.5%0.1 $2.13 4/30/202013,900 shares $22,518.00 -48.5%0.4%0 $1.62 4/15/202027,000 shares $45,630.00 -9.7%0.7%0.1 $1.69 3/31/202029,900 shares $45,149.00 +22.5%0.8%0.1 $1.51 3/13/202024,400 shares $37,820.00 -16.7%0.7%0.4 $1.55 2/28/202029,300 shares $30,765.00 +1.7%0.8%0.2 $1.05 2/14/202028,800 shares $49,824.00 -6.2%0.8%0.2 $1.73 1/31/202030,700 shares $59,865.00 -42.1%0.8%0.1 $1.95 1/15/202053,000 shares $115,540.00 -20.3%1.5%0.1 $2.18 12/31/201966,500 shares $154,945.00 -18.2%1.8%0.1 $2.33 PSTV Short Interest - Frequently Asked Questions What is Plus Therapeutics' current short interest? Short interest is the volume of Plus Therapeutics shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 52,300 shares of PSTV short. 0.91% of Plus Therapeutics' shares are currently sold short. Learn More on Plus Therapeutics' current short interest. What is a good short interest ratio for Plus Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PSTV shares currently have a short interest ratio of 1.0. Learn More on Plus Therapeutics's short interest ratio. What is a good short interest percentage for Plus Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.91% of Plus Therapeutics' floating shares are currently sold short. Is Plus Therapeutics' short interest increasing or decreasing? Plus Therapeutics saw a decline in short interest during the month of October. As of October 31st, there was short interest totaling 52,300 shares, a decline of 3.1% from the previous total of 54,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Plus Therapeutics' float size? Plus Therapeutics currently has issued a total of 5,900,000 shares. Some of Plus Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Plus Therapeutics currently has a public float of 5,750,000 shares. How does Plus Therapeutics' short interest compare to its competitors? 0.91% of Plus Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to Plus Therapeutics: DarioHealth Corp. (5.40%), Spectral AI, Inc. (11.59%), Beyond Air, Inc. (3.07%), IRIDEX Co. (2.49%), Femasys Inc. (2.56%), ReWalk Robotics Ltd. (1.94%), Neuronetics, Inc. (2.42%), NEXGEL, Inc. (0.49%), Lyra Therapeutics, Inc. (3.12%), Nephros, Inc. (0.12%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Plus Therapeutics stock? Short selling PSTV is an investing strategy that aims to generate trading profit from Plus Therapeutics as its price is falling. PSTV shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Plus Therapeutics? A short squeeze for Plus Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PSTV, which in turn drives the price of the stock up even further. How often is Plus Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PSTV, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies DarioHealth Short Squeeze Spectral AI Short Squeeze Beyond Air Short Squeeze IRIDEX Short Squeeze Femasys Short Squeeze ReWalk Robotics Short Squeeze Neuronetics Short Squeeze NEXGEL Short Squeeze Lyra Therapeutics Short Squeeze Nephros Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PSTV) was last updated on 11/13/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Plus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Plus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
